US Warrant News

Senmiao Technology Announces Entry into Agreements for Registered Direct Public Offering of $6.0 Million of Common Stock and Warrants – PRNewswire

Senmiao Technology Announces Entry into Agreements for Registered Direct Public Offering of $6.0 Million of Common Stock and Warrants PRNewswire CHENGDU, China, June 18, 2019 /PRNewswire/ — Senmiao Technology Limited (Senmiao) (NASDAQ: AIHS), an operator of an online lending marketplace …

Senmiao Technology Announces Entry into Agreements for Registered Direct Public Offering of $6.0 Million of Common Stock and Warrants – PRNewswire Read More »

Senmiao Technology Announces Entry into Agreements for Registered Direct Public Offering of $6.0 Million of Common Stock and Warrants – Yahoo Finance

Senmiao Technology Announces Entry into Agreements for Registered Direct Public Offering of $6.0 Million of Common Stock and Warrants Yahoo Finance CHENGDU, China, June 18, 2019 /PRNewswire/ — Senmiao Technology Limited (Senmiao) (AIHS), an operator of an online lending marketplace connecting …

Senmiao Technology Announces Entry into Agreements for Registered Direct Public Offering of $6.0 Million of Common Stock and Warrants – Yahoo Finance Read More »

Arcadia Biosciences Announces Closing of $7.5 Million Registered Direct Offering Priced At-the-Market – Yahoo Finance

Arcadia Biosciences Announces Closing of $7.5 Million Registered Direct Offering Priced At-the-Market Yahoo Finance Net Proceeds to Fuel Hemp Research, Innovation and Scale-Up of GoodWheat™. DAVIS, Calif., June 18, 2019 /PRNewswire/ — Arcadia Biosciences, Inc.

Arcadia Biosciences Announces Closing of $7.5 Million Registered Direct Offering Priced At-the-Market – Yahoo Finance Read More »

ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering – Yahoo Finance

ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering Yahoo Finance ContraVir Pharmaceuticals, Inc. (“ContraVir,” the “Company,” “we,” “our” or “us”) (CTRV), a biopharmaceutical company focused on the development of …

ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering – Yahoo Finance Read More »

Scroll to Top